Header cover image

Swiss Pharmaceuticals & Biotech Blue chip stocks

Results

3

0 new

3 companies

Sandoz Group

Market Cap: CHF 29.8b

Develops, manufactures, and markets generic and biosimilars worldwide.

SDZ

CHF 68.78

7D

4.2%

1Y

58.5%

Lonza Group

Market Cap: CHF 34.5b

Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.

LONN

CHF 493.30

7D

-1.1%

1Y

-11.8%

Galderma Group

Market Cap: CHF 40.5b

Operates as a dermatology company worldwide.

GALD

CHF 172.85

7D

3.7%

1Y

56.1%